Menu

Mergers & Acquisitions

1,000+ M&A transactions for an aggregate value of $555+ billion since 2020

Why Cooley
  • 180+ member team in 18 major business and technology centers in the US, Europe and Asia
  • Broad industry platform with clients across many industries and sophisticated capabilities in all practice areas
  • Excel in deals in the tech, life sciences, medical device and healthcare, consumer, education, defense and media industries
  • Given our market position in the medtech and life sciences sectors, we have handled a large number of life sciences M&A transactions, both public and private, and understand unique structuring issues for life sciences companies, including milestone structures, contingent value rights and option structures
  • Primary corporate counsel to 240+ public companies, giving us an unmatched perspective on market deal points and ability to facilitate introductions between buyers and sellers
  • Represent all categories of participants in transactions, including buyers, sellers, major stockholders, venture capitalists, lenders, financial advisors, management/founders, special board committees, individual investors, private equity funds, hedge funds and others 
  • Adept at handling all manner of transactions, including domestic and cross-border mergers and acquisitions, strategic deals including joint ventures, acquisitions of IP assets, patent cross-licenses, complex divestitures and spin-offs, takeover defense and shareholder activism counseling, and multibillion-dollar public company mergers
  • Robust SPAC experience and thought leaders in the area with a repository of market insight and guidance for businesses interested in the IPO alternative @ SPACtivity 
  • Market-leading IP, privacy, technology licensing, life sciences collaborations and licensing, regulatory, government contracts, credit finance, private equity, antitrust, employment, compensation and tax practices to support transactions

M&A Blog

Newsworthy developments in the global mergers and acquisitions space

View blog

Recognition

  • Chambers: Ranked for USA - Nationwide Corporate/M&A (2022)
  • Bloomberg: Top 2 for Global, US and UK M&A by Deal Count (2022)
  • Bloomberg: #1 for Global and US Mid-market M&A (2022)
  • Mergermarket: Top 5 for Global M&A by Deal Count (2022)
  • Mergermarket: Top 3 for US M&A by Deal Count (2022)
  • Refinitiv: Top 6 for Global M&A by Deal Count (2022)
  • Refinitiv: Top 4 for US M&A by Deal Count (2022)

Public Company Innovation Hub

Resources for forward-thinking board members and leaders of US-listed public companies

Visit hub

Global Business Hub

Resources for US companies to launch and succeed in new global markets

Visit hub

Group contacts
Barbara Borden  Partner San Diego
Jamie Leigh  Partner San Francisco
Steve Tonsfeldt  Partner Palo Alto
Garth Angelo Osterman  Partner San Francisco
Rama Padmanabhan  Partner San Diego
Kevin Mills  Senior Counsel Washington, DC
Ian A. Nussbaum  Partner New York
Alfred Browne  Partner Boston
Laura M. Medina  Partner Colorado
Justin Stock  Managing Partner – London London
David Bresnick  Partner London
Michal Berkner  Partner London
Stephen Rosen  Partner London
Christina Zhang  Partner in Charge – Shanghai Shanghai, San Diego
Joshua Holleman  Partner Washington, DC
Miguel J. Vega  Partner Boston
Ben Beerle  Partner San Francisco
Aaron Binstock  Partner Washington, DC
Erin J. Kirchner  Partner Chicago
Kevin Cooper  Partner New York
Neal I. Aizenstein  Partner Chicago
Anne Lieberman  Partner Los Angeles – Santa Monica, Los Angeles – Downtown
David Silverman  Partner New York
Ben Shribman  Partner London
Nick Davis  Partner Seattle
Bill Sorabella  Partner New York
Ruomu Li  Partner Shanghai
Bram G. Couvreur  Partner Los Angeles – Santa Monica, Los Angeles – Downtown
Bill Roegge  Partner New York
ViewHide related contacts


Error

Listing Returned 0 Results.

ViewHide related news


Error

Listing Returned 0 Results.

ViewHide related events


Error

Listing Returned 0 Results.